Table 1 Relationship between LAPTM4B-35 expression and clinicopathological features of patients with head and neck cancer.
Variables | Patient number | LAPTM4B-35 expression | p-value | |
|---|---|---|---|---|
low | high | |||
Age | 0.265 | |||
<60 | 68 | 39 (57.4%) | 29 (42.6%) | |
>60 | 59 | 28 (47.5%) | 31 (52.5%) | |
Gender | 0.047 | |||
Male | 98 | 47 (48.0%) | 51 (52.0%) | |
Female | 29 | 20 (69.0%) | 9 (31.0%) | |
Anatomical site | 0.096 | |||
Oral cavity | 36 | 13 (36.1%) | 23 (63.9%) | |
Oropharynx | 56 | 35 (62.5%) | 21 (37.5%) | |
Hypopharynx | 21 | 12 (57.1%) | 9 (42.9%) | |
Larynx | 14 | 7 (50.0%) | 7 (50.0%) | |
Lymph node metastasis | 0.070 | |||
Yes | 99 | 48 (48.5%) | 51 (51.5%) | |
No | 28 | 19 (67.9%) | 9 (32.1%) | |
UICC stage | 0.017 | |||
I | 3 | 0 (0.0%) | 3 (100%) | |
II | 17 | 13 (76.5%) | 4 (23.5%) | |
III | 30 | 19 (63.3%) | 11 (36.7%) | |
IV | 77 | 35 (45.5%) | 42 (54.5%) | |
N classification | <0.001 | |||
0 | 28 | 19 (67.9%) | 9 (32.1%) | |
1 | 30 | 16 (53.3%) | 14 (46.7%) | |
2a | 8 | 2 (25.0%) | 6 (75.0%) | |
2b | 45 | 19 (42.2%) | 26 (57.8%) | |
2c | 13 | 10 (76.9%) | 3 (23.1%) | |
3 | 3 | 1 (33.3%) | 2 (66.7%) | |
T classification | <0.001 | |||
1 | 25 | 12 (48%) | 13 (52%) | |
2 | 68 | 40 (58.8%) | 28 (41.2%) | |
3 | 21 | 11 (52.4%) | 10 (47.6%) | |
4a | 13 | 4 (30.8%) | 9 (69.2%) | |
